Corporate Office of Research Oversight

The Corporate Office of Research Oversight (CORO) is responsible for supporting investigators and administrators in research by managing investigator-initiated research, academic, cooperative group, and externally sponsored research projects and clinical trials.

CORO processes approximately 200 applications annually for Orlando Health. The Office provides training to investigators, administrators and research operations teams and is available to provide customized consultative services to investigators and administrators.

Our Vision

The Corporate Office of Research Oversight will create an outstanding climate of support for Orlando Health researchers, enabling exceptional research advances.

Our Missions

To enable the achievement of excellence by the research community, the Corporate Office of Research Oversight:

  • Partners with the research community to create a culture of high achievement

  • Promotes shared responsibility, the ethical conduct of research, and compliance

  • Enhances researchers' abilities to obtain and manage grants

  • Advocates for the needs of the Orlando Health research community

  • Broadens awareness of the value of Orlando Health research

  • Enhances the ability to perform research in a global community

  • Supports strong infrastructure for interdisciplinary research

Staff Members

Corporate Office of Research Oversight

Philip Giordano, MD

Chief, Corporate Research and Operations

Kurt Weber, MD

Senior Director, Corporate Office of Research Oversight

Tara Roberts, CIM, CIP

AVP, Research Regulation and Compliance

Allisun Feazell, CIP, CCRP

Senior Director, Corporate Office of Research Oversight

Vicky Awalt

Senior Director, Research Revenue Compliance

Renzo Brothers

Senior Clinical Research Revenue Specialist

Elkie Lo

Administrative Assistant

Clinical Research Divisions

  • Biorepository

  • Cancer Institute

  • Cardiovascular and Peripheral Vascular

  • Clinical Grants

  • Digestive Health Institute

  • Emergency Medicine

  • Neonatal Intensive Care Unit (NICU)

  • Neuroscience Institute

  • Obstetric/ Gynecological

  • Orthopedics and Sports Medicine

  • Pediatric Cardiology

  • Pediatric Cardiothoracic Surgery

  • Pediatric Endocrine

  • Pediatric Gastrointestinal

  • Pediatric Neurology

  • Pediatric Oncology

  • Pediatric Orthopedics

  • Traumatic Brain Injury

Orlando Health Policy on Financial Conflicts of Interest of Investigators and Staff

In accordance with 42 CFR Part 50 Subpart F, "Responsibility of Applicants for Promoting Objectivity in Research for which Public Health Service Funding is Sought", please reference the Orlando Health Policy on Financial Conflicts of Interest of Investigators and Research Staff. To review policy please click "Learn More" below:

Helpful Resources Links:

U.S. Food and Drug Administration (FDA)

U.S. Food and Drug Administration (FDA)

Institutional Review Board (IRB)

Institutional Review Board (IRB)

National Institutes of Health (NIH)

National Institutes of Health (NIH)

Orlando Health Institutional Review Board (Orlando Health IRB)

Orlando Health Institutional Review Board (Orlando Health IRB)

Office for Human Research Protections (OHRP)

Office for Human Research Protections (OHRP)